Claims and structured electronic health record (EHR) data are tried-and-true real-world data (RWD) sources — life sciences researchers have trusted these data for years, answering questions from pre-clinical to post-launch.
But, what if more information is required, beyond what is typically captured in structured claims and EHR data? What if additional details are required about disease progression, lifestyle behaviors or treatment response that do not fit neatly into traditional data fields? Multi-modal data sources can provide this more granular, high-value patient data.
With increasingly competitive therapeutic markets, shifting payer priorities and complex patient subpopulations, the evidence generation stakes are higher than ever. The use of enriched clinical data, unstructured clinical notes and genomic data presents opportunities to analyze and fully understand the patient journey from a different lens.
In this webinar, the expert speakers will have an in-depth conversation on applications and use cases for these multi-modal data, including how to determine the fit-for-purpose nature of a data set and ways that these data can help organizations continue innovating and helping patients in a dynamic, evolving market.
Register for this webinar today to explore how multi-modal data sources can provide insights into patient journeys and enhance evidence generation.
Speakers
Lou Brooks, Senior Vice President, Real-World Data and Analytics, Optum Life Sciences
Lou Brooks leads a team of individuals responsible for the development and deployment of healthcare data solutions that enable organizations to fuel their real-world evidence generation activities to support the development and commercialization of healthcare products and services.
Over the past 25 years, he has led a variety of real-world data analytics teams, all of which focused on developing a better understanding of customer behavior across several industries, including telecommunications, pharmaceutical products and consumer packaged goods.
Lou has worked in the pharmaceutical industry since 1997. During his tenure at Optum, Lou has been focused on continuing to drive real-world-based data projects using claims and EMR data, as well as developing technology solutions that enable analytics to be packaged and executed in a more efficient, effective manner. Lou has experience across a variety of therapeutic areas, including autoimmune disorders, diabetes, respiratory, CNS, oncology and cardiovascular conditions.
Message Presenter
Erin Hulbert, Director, Value-Based Contracting and Services, Optum Life Sciences
Erin Hulbert leads the value-based contracting and services (VBC) team for Optum Life Sciences. The team measures outcomes to support rebates for value-based agreements and partners with life sciences companies to successfully navigate the contracting landscape and communicate the value of their products to payers.
She has extensive experience using real-world evidence (RWE) for outcomes analysis and research across therapeutic areas. She is an expert in observational and prospective methodologies across projects using administrative claims, clinical data, medical charts, surveys and clinical trials.
Her work has been published in peer-reviewed journals such as the Journal of Managed Care Specialty Pharmacy and American Journal of Pharmacy Benefits. She holds an MS in Health Services Research, Policy and Administration from the University of Minnesota School of Public Health and an MBA from the Carlson School of Management at the University of Minnesota.
Message Presenter
Danita Kiser, Vice President, Innovation and Strategy, UnitedHealth Group
Danita Kiser is VP of Innovation and Strategy in the UHG Chief Innovation Office where her focus is business growth through large-scale enterprise data platform strategies. Her diverse career has focused on driving business transformation and growth through technology enablement across multiple sectors and Fortune 50 companies, including health care, telecommunications, consumer electronics and digital media.
In her nine years at UHG, Danita has built expertise in computation epidemiology, including infectious diseases, machine learning and artificial intelligence and product/business strategy. She has a PhD in Chemistry from Emory University, MS in Chemistry and Education and a BS in Chemistry and Math.
Message PresenterWho Should Attend?
This webinar will appeal to professionals from the following fields:
- Real-world evidence (RWE)
- Real-world data (RWD)
- Data science
- Data and analytics
- Observational research
- Value and evidence generation
- Health economics and outcomes research (HEOR)
- Medical affairs
What You Will Learn
Attendees will learn about:
- How multi-modal data have the potential to enhance life sciences research
- The current challenges and opportunities for employing these data
- Practical applications of multi-modal data with real-life example research studies
Xtalks Partner
Optum
Optum Life Sciences, a part of UnitedHealth Group’s Innovation and Growth Platform, is a leading real-world data and consulting company that connects the life sciences industry to the rest of the health care ecosystem to catalyze innovation and impact. Life sciences leaders trust our robust real-world data and experienced consultants to connect the dots in ways that answer tough questions, illuminate new possibilities and improve patient lives. Additionally, our experts can help you anticipate and address the demands of payers, providers, patients and regulators throughout the product lifecycle, and our enterprise connections across all sectors of health care help accelerate clinical development and improve population health. For more information, go to www.optum.com/life-sciences.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account